Head
neck
cancers
sixth
common
cancer
world
predominant
type
consist
squamous
cell
carcinomas
(
head
neck
squamous
cell
carcinoma
,
HNSCC
)
.

Besides
tobacco
smoking
alcohol
consumption
,
human
papilloma
virus
(
HPV
)
infection
third
leading
cause
occurrence
HNSCC
.

The
presence
HPV
distinct
group
head
neck
cancers
exhibiting
epidemiological
,
histopathological
,
clinical
prognostic
differences
opposed
typical
HNSCC
.

HPV
positive
HNSCC
normally
favorable
prognosis
compared
HPV
negative
HNSCC
,
biomarkers
suitable
early
detection
HPV
positive
HNSCC
developed
urgently
improve
patient
outcomes
.

HPV
DNA
screening
sensitive
,
probably
useful
high
prevalence
oral
HPV
low
risk
HNSCC
.

MicroRNAs
(
miRNAs
)
constitute
class
small
non-coding
RNAs
act
post-transcriptional
regulators
gene
expression
.

Since
miRNAs
role
cancer
development
HPV
status
may
affect
miRNAs
expression
pattern
HNSCC
,
specific
miRNAs
'
expression
HPV
positive
HNSCC
may
expound
role
HPV
HNSCC
new
biomarkers
early
detection
HNSCC
.

More
excitingly
,
saliva
proximal
biofluid
context
HNSCC
contains
good
deal
miRNAs
.

These
miRNAs
stabile
may
suitable
noninvasive
biomarkers
HNSCC
.

